Delivery Order SPE2DB22D1002-SPE2DB25FKUY0
Award Date
11/27/24
Potential Completion Date
11/29/24
Potential Value
$1.7K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of Ozempic 0.25-0.5 mg/dose pens to the Defense Logistics Agency (DLA) Medical Supply Chain, a defense agency. The contract has a ceiling value of $1,091.88 and a performance period through January 31, 2024. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. Amerisourcebergen is a subsidiary of the parent company Cencora, Inc. The contract was awarded as a firm fixed-price...
This federal contract award is for the delivery of Ozempic 0.25-0.5 mg/dose pens with a 3 ml capacity. The contract, valued at $3,531.84, was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) on November 6, 2024. The contract has a completion date of November 7, 2024 and is a firm fixed-price delivery order. The contract is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC)...
This federal contract award is for the delivery of Ozempic 0.25-0.5 mg/dose pens (3 ml) to the Defense Logistics Agency (DLA), a defense agency. The $7,177.37 firm fixed price contract was awarded to Amerisourcebergen Drug Corporation's Corporate Office division, a major pharmaceutical distributor, on June 27, 2024, with a completion date of June 28, 2024. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support...
This federal contract award is for the delivery of Ozempic 0.25-0.5 mg/dose pens to the Defense Logistics Agency (DLA) Troop Support Medical, a defense agency. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $1,610.97 and a completion date of December 17, 2024. It is a delivery order under an Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999 and running through...
This federal contract award is for the delivery of Ozempic 0.25-0.5 mg/dose pens by Amerisourcebergen Drug Corp to the U.S. government's Defense Logistics Agency (DLA) Troop Support Medical. The contract has a firm fixed price of $4,612.53 and a completion date of June 20, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical worth up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the primary vehicle for...
This federal contract award is for the delivery of Ozempic 0.25-0.5 mg/dose pens with a 3 mL capacity to the Defense Logistics Agency (DLA). The $1,871.54 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on March 30, 2023. The contract has an ultimate completion date of March 31, 2023 and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999...
This federal contract award is for the delivery of Ozempic 0.25-0.5 mg/dose pens to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider registered in the System for Award Management. The contract has a ceiling value of $1,161.08 and a period of performance through March 10, 2023. It is a delivery order contract with a firm fixed price pricing type. This award is not designated as a set-aside...
This federal contract award is for the delivery of Ozempic 0.25-0.5 mg/dose pens (3 ml) to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price of $33,821.56 and a completion date of June 12, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop...
This federal contract award is for the delivery of Ozempic 0.25-0.5 mg/dose pen 3ml to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, and has a ceiling value of $8,815.10. The contract is a Firm Fixed Price Delivery Order and is not associated with any set-aside designation. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to...
This federal contract award is for the delivery of Ozempic 0.25-0.5 mg/dose pens with a 3 mL volume to the Defense Logistics Agency (DLA). The contract has a ceiling value of $17,606.02 and is a firm fixed-price delivery order with a performance period ending on May 9, 2025. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. This contract is not set aside and is an open competition award. Amerisourcebergen Drug Corp also...